Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes
Ferdinand KC, Nasser SA. Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus. Curr Med Res Opin 2015;31:913–923
This article is a narrative review of the epidemiological data available on diabetes prevalence and care and of studies indexed in PubMed involving trials that evaluated treatments for type 2 diabetes in racial minority populations. The authors examined data from the Centers for Disease Control and Prevention and from the National Health and Nutrition Examination Survey. Table 1 provides a summary of demographic data (1–7). Because of the difficulties in gathering data for all three large racial and ethnic minorities in the United States, disparities are presented solely for African Americans compared to whites and for Hispanics compared to whites. The prevalence of diagnosed type 2 diabetes by racial/ethnic group is as follows: Asians 9.0%, African Americans 13.2%, Hispanic 12.8%, and non-Hispanic whites 7.6%. There is a wide variation in prevalance in the Native American population (e.g., 6.0% in Alaskan Natives and 24.1% in southern Arizona Native American groups) and among Hispanics (e.g., 8.5% in Central/South Americans, 9.3% in Cubans, 13.9% in Mexican Americans, and 14.8% in Puerto Ricans) (8).
Objective. The purpose of this study was to identify and describe all clinical drug trials for type 2 diabetes that included Asians, African Americans, or Hispanics.
Design. The authors conducted a literature review of studies indexed in MEDLINE and accessed through PubMed.
Methods. The authors searched …